三倍做空标普生物-Direxion(LABD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LABD 三倍做空标普生物-Direxion

休市中 07-02 16:00:00 EDT

7.38

-0.57

-7.17%

盘后7.41

+0.03+0.41%

19:59 EDT

最高7.98	最低7.33	成交量1,791万
今开7.84	昨收7.95	日振幅8.24%
总市值6,942万	流通市值6,942万	总股本940.65万
成交额1.37亿	换手率190.37%	流通股本940.65万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LABD","market":"US","secType":"STK","nameCN":"三倍做空标普生物-Direxion","latestPrice":7.38,"timestamp":1783022400000,"preClose":7.95,"halted":0,"volume":17907515,"hourTrading":{"tag":"盘后","latestPrice":7.41,"preClose":7.38,"latestTime":"19:59 EDT","volume":132496,"amount":984248.6387,"timestamp":1783036797011,"change":0.03,"changeRate":0.004065,"amplitude":0.012195},"delay":0,"changeRate":-0.07169811320754721,"floatShares":9406480,"shares":9406480,"eps":0,"marketStatus":"休市中","change":-0.57,"latestTime":"07-02 16:00:00 EDT","open":7.84,"high":7.98,"low":7.325,"amount":136846534.5489925,"amplitude":0.08239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":-3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":7.95,"sharesOutstanding":3706480,"nav":7.367,"aum":69302044.76,"dividendRate":0.08794,"bidAskSpread":0.001355,"preHourTrading":{"tag":"盘前","latestPrice":7.84,"preClose":7.96,"latestTime":"09:29 EDT","volume":44384,"amount":347588.36937599996,"timestamp":1782998999999,"change":-0.12,"changeRate":-0.015075,"amplitude":0.048141},"postHourTrading":{"tag":"盘后","latestPrice":7.41,"preClose":7.38,"latestTime":"19:59 EDT","volume":132496,"amount":984248.6387,"timestamp":1783036797011,"change":0.03,"changeRate":0.004065,"amplitude":0.012195},"volumeRatio":1.2728221056824505,"impliedVol":0.8805,"impliedVolPercentile":0.796},"requestUrl":"/m/hq/s/LABD","defaultTab":"news","newsList":[{"id":"1162099302","title":"诺瓦瓦克斯医药上调2026年调整后营收预期，受疫苗交易强劲表现提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1162099302","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162099302?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:07","pubTimestamp":1772118465,"startTime":"0","endTime":"0","summary":"周四， $诺瓦瓦克斯医药$ 上调了其2026年调整后营收预测，称预计来自疫苗供应和授权协议的里程碑付款将抵消需求疲软带来的压力。这家生物科技公司目前预计，2026年调整后营收将在2.30亿美元至2.70亿美元之间，高于此前预计的1.85亿美元至2.05亿美元。Novavax预计将在2028年前实现盈利，主要受益于其与Sanofi合作协议中的关键产品上市，包括一款采用其Nuvaxovid疫苗的COVID-流感二联疫苗。受消息影响， $诺瓦瓦克斯医药$ 升19%。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺瓦瓦克斯医药上调2026年调整后营收预期，受疫苗交易强劲表现提振","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","LABD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127867080","title":"美股生物医药股集体上扬！Moderna涨超7%，Sarepta Therapeutics涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127867080","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127867080?lang=zh_cn&edition=full","pubTime":"2026-01-06 23:04","pubTimestamp":1767711863,"startTime":"0","endTime":"0","summary":"1月6日，美股生物医药股集体上扬，$Moderna(MRNA)$涨超7%，$Sarepta Therapeutics(SRPT)$涨超6%，$诺和诺德(NVO)$、$诺瓦瓦克斯医药(NVAX)$涨超5%，$葛兰素史克(GSK)$涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","SRPT","LABD","BK4585","IE00B2B36J28.USD","IE00BJT1NW94.SGD","NVO","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4539","BK4007","IE0002141913.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111279193","title":"受益于与艾伯维的合作，Ironwood医药2026年业绩指引超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1111279193","media":"老虎资讯综合","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111279193?lang=zh_cn&edition=full","pubTime":"2026-01-02 20:41","pubTimestamp":1767357698,"startTime":"0","endTime":"0","summary":"Linzess 的净销售额预计将上升。","market":"us","thumbnail":"https://community-static.tradeup.com/news/69f1e6dad8f03a67222d629220701122","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/69f1e6dad8f03a67222d629220701122"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"受益于与艾伯维的合作，Ironwood医药2026年业绩指引超市场预期","news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRWD","LABD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1633},{"period":"1month","weight":-0.522},{"period":"3month","weight":-0.5329},{"period":"6month","weight":-0.6534},{"period":"1year","weight":-0.8943},{"period":"ytd","weight":-0.6496}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.039916},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.034987},{"month":3,"riseRate":0.636364,"avgChangeRate":0.015575},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.011715},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.066088},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.176609},{"month":7,"riseRate":0.25,"avgChangeRate":-0.071036},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.02872},{"month":9,"riseRate":0.636364,"avgChangeRate":0.044192},{"month":10,"riseRate":0.545455,"avgChangeRate":0.055825},{"month":11,"riseRate":0.090909,"avgChangeRate":-0.202304},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.002829}],"exchange":"ARCA","name":"三倍做空标普生物-Direxion","nameEN":"Direxion Daily S&P Biotech Bear 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三倍做空标普生物-Direxion(LABD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三倍做空标普生物-Direxion(LABD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三倍做空标普生物-Direxion,LABD,三倍做空标普生物-Direxion股票,三倍做空标普生物-Direxion股票老虎,三倍做空标普生物-Direxion股票老虎国际,三倍做空标普生物-Direxion行情,三倍做空标普生物-Direxion股票行情,三倍做空标普生物-Direxion股价,三倍做空标普生物-Direxion股市,三倍做空标普生物-Direxion股票价格,三倍做空标普生物-Direxion股票交易,三倍做空标普生物-Direxion股票购买,三倍做空标普生物-Direxion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三倍做空标普生物-Direxion(LABD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三倍做空标普生物-Direxion(LABD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}